Our study provides a new insight into the risk of developing hypertension in diabetes associated with OPG gene polymorphism and the difference in the risk profile in terms of altered level of RANKL, osteoprotegerin, inflammation and autonomic control. This evidence concerns the gene TNFRSF11B and hypertensive disorder.